Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
This 29-amino-acid fragment contains the complete biologically active region required to stimulate growth hormone release in experimental models
Retatrutide (LY3437943) is Eli Lillys experimental triple-agonist drug that activates: GLP-1 (Glucagon-like peptide-1) reduces appetite and slows digestion GIP (Glucose-dependent insulinotropic peptide) enhances insulin sensitivity Glucagon receptor increases fat metabolism and energy expenditure In phase-2 trials, Retatrutide achieved up to 24% body-weight reduction rivaling or even surpassing bariatric surgery outcomes
This may be related to its potential to decrease the burden of senescent cells
Should I take B12 supplements if I'm on Mounjaro for weight loss
US$ 26.56
US$ 29.74
US$ 27.00
